IMACS First Annual Report

Slides:



Advertisements
Similar presentations
Chapter 4: Cardiovascular Disease in Patients With CKD 2014 A NNUAL D ATA R EPORT V OLUME 1: C HRONIC K IDNEY D ISEASE.
Advertisements

Chapter 2: Identification and Care of Patients With CKD 2014 ANNUAL DATA REPORT VOLUME 1: CHRONIC KIDNEY DISEASE.
Preliminary results from the C-Pulse OPTIONS HF European Multicenter Post-Market Study Holger Hotz, CardioCentrum Berlin, Berlin, Germany; Antonia Schulz,
Between May 2013 and June 2014, we implanted the C-Pulse device in 7 male and 1 female patients with a mean age ± SD of 61.1 ± 9.4 years. Four had ischemic.
December Cardiac Rehabilitation Are you or someone you know missing the benefits of Cardiac Rehabilitation?
Predicting Patients at Risk for Poor Global Outcomes after DT- MCS Therapy Suzanne V. Arnold, MD, MHA Saint Luke’s Mid America Heart Institute/UMKC May.
Periportal Fibrosis Without Cirrhosis Does Not Affect Outcomes Following Continuous Flow Ventricular Assist Device Implantation Jonathon E. Sargent, BS,
Predicting Major Outcomes after MCSD Implant 1 Risk Factors for Death, Transplant, and Recovery James Kirklin, MD David Naftel, PhD.
Kotseva K, et al. Eur J Cardiovasc Prev Rehabil 2009 Mar 12 [Epub]
Atherosclerosis by Sidrah naseem (ug-3). Arteries are blood vessels that carry oxygen and nutrients from your heart to the rest of your body. Healthy.
ALPHA OMEGA: Effect of low doses of n-3 fatty acids on cardiovascular diseases in post-MI patients Daan Kromhout, MPH PhD for the Alpha Omega Trial Group.
Red Cell Distribution Width (RDW) as a Novel Prognostic Marker in Heart Failure: Data from the CHARM Program and the Duke Databank.
Primary ESRD Modality in New ESRD Patients, * New Patients (%) *Reported on HCFA Medical Evidence Form USRDS 1999 IV -1.
Long-term Benefits of Surgical Pulmonary Embolectomy for Acute Pulmonary Embolus on Right Ventricular Function Brent Keeling MD 1, Bradley G. Leshnower.
Development of a novel predictive model for mortality post continuous flow LVAD implant using Bayesian Networks (BN) N. A. Loghmanpour 1, M. K. Kanwar.
Chapter 4: Cardiovascular Disease in Patients With CKD 2015 A NNUAL D ATA R EPORT V OLUME 1: C HRONIC K IDNEY D ISEASE.
2015 ANNUAL DATA REPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE Chapter 9: Cardiovascular Disease in Patients With ESRD.
PREDICTORS FOR IN HOSPITAL MORTALITY IN PATIENTS WITH TYPE A AORTIC DISSECTION FROM A TWO CENTRE EXPERIENCE S Leontyev, J Légaré, MA Borger, K Buth, AK.
Date of download: 6/28/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Urinary Sodium and Potassium Excretion and Risk of.
Powered by Infomedica Infomedica Conference Coverage* of 26 th European Meeting on Hypertension and Cardiovascular Protection Paris (France), June 10-13,
Management of Hypertension according to JNC 7
2016 Annual Data Report, Vol 1, CKD, Ch 4
An AKI project for critically ill cancer patients
Figure 9.1 Causes of death in ESRD patients,
- Higher SBP visit-to-visit variability (SBV) has been associated
Alcohol, Other Drugs, and Health: Current Evidence July–August 2017
From ESH 2016 | LB 3: Davide Agnoletti, MD
Copyright © 2011 American Medical Association. All rights reserved.
Copyright © 2014 American Medical Association. All rights reserved.
Specialist Cardiologist at Sydney. Macquarie University Hospital Cardiology at Macquarie University Hospital, a team of specialist cardiologist, who diagnose.
The Spanish Data Bank PEGASO M. Martínez-Sellés
Patient populations by study group figure 10
All-cause mortality by treatment group
Procedural factors associated with PCI-related ischemic stroke
2016 Annual Data Report, Vol 1, CKD, Ch 2
Volume 1: Chronic Kidney Disease
THE APPLICATION OF TELECARE FOR PATIENTS WITH CARDIOVASCULAR DISEASE
The Relationship Between Ultraviolet Light Exposure and Mortality in Dialysis Patients Am J Nephrol 2014;40: DOI: / Fig. 1. Association.
Fifth INTERMACS annual report: Risk factor analysis from more than 6,000 mechanical circulatory support patients  James K. Kirklin, MD, David C. Naftel,
ECMO and advanced intensive care Euro-Elso 2013
Association of low eosinophil and lymphocyte counts with different initial presentations of cardiovascular disease over the first 6 months ‘Low eosinophils’
Chapter 4: Cardiovascular Disease in Patients with CKD
Shoshana H. Ballew, PhD, Yan Chen, BS, Natalie R. Daya, MPH, Job G
Predictors of 30-day hospital readmission after coronary artery bypass
Morbidity of Bleeding After Cardiac Surgery: Is It Blood Transfusion, Reoperation for Bleeding, or Both?  Alessandro Vivacqua, MD, Colleen G. Koch, MD,
Annual Fall Meeting November 13, 2016
Intraaortic balloon pumping for predominantly right ventricular failure after heart transplantation  Osama E Arafa, MD, Odd R Geiran, MD, PhD, Kai Andersen,
Hemodynamic and physiologic changes during support with an implantable left ventricular assist device  Patrick M. McCarthy, MD (by invitation), Robert.
Dileep Raman et al. JACEP 2017;3:
Trends in Acute Kidney Injury, Associated Use of Dialysis, and Mortality After Cardiac Surgery, 1999 to 2008  Colin R. Lenihan, MBBCh, BAO, Maria E. Montez-Rath,
New-Onset Postoperative Atrial Fibrillation and Long-Term Survival After Aortic Valve Replacement Surgery  Giovanni Filardo, PhD, MPH, Cody Hamilton,
Clostridium difficile infection after cardiac surgery: Prevalence, morbidity, mortality, and resource utilization  Suresh Keshavamurthy, MBBS, MS, Colleen.
Lu Dai, MSc, Stephanie L. Mick, MD, Keith R. McCrae, MD, Penny L
Five-Year Outcomes after Randomization to Transcatheter or Surgical Aortic Valve Replacement: Final Results of The PARTNER 1 Trial Michael J. Mack, MD.
Figure 1 Diagram showing analysis flow of patient selection and treatment allocation of ONTARGET/TRANSCEND. Figure 1 Diagram showing analysis flow of patient.
Vitality Measured as Self-reported Energy Level and Clinical Outcomes in Hemodialysis Patients: The Japanese Dialysis Outcomes and Practice Pattern Study.
Off-pump versus on-pump coronary artery bypass grafting: Insights from the Arterial Revascularization Trial  Umberto Benedetto, MD, PhD, Douglas G. Altman,
CHAMPION Trial design: Patients with recent hospitalization for heart failure were implanted with a pulmonary artery pressure monitor and randomized so.
Connie W. Tsao et al. JCHF 2016;4:
Characteristics of 21,484 Patients With MI Who Survived for >30 Days After Discharge, by Calendar Year - Part I Soko Setoguchi, et al. J Am Coll Cardiol.
Baseline Characteristics of the Subjects*
Atlantic Cardiovascular Patient Outcomes Research Team
Areef Ishani, Allan J. Collins, Charles A. Herzog, Robert N. Foley 
Shoshana H. Ballew, PhD, Yan Chen, BS, Natalie R. Daya, MPH, Job G
Low/moderate intensity statins High intensity statins
Rick A. Nishimura et al. JACC 2017;70:
Low/moderate intensity statins High intensity statins
Change in 6 min walk distance at 12 months in subgroups defined by baseline characteristics. The mean (95% CI) for the difference between CABG and medical.
Figure 9.1.a Causes of death in ESRD patients,
A – Demographic, Anthropometric and Clinical correlates of plasma NT-proBNP levels stratified by race: Multivariable Regression Results (Multivariable.
Presentation transcript:

IMACS First Annual Report Appendix 1. IMACS – Participating Hospitals (n = 17, Coverage: 1/9/2013-12/31/2014). City Country Hospital Perth Australia Western Fiona Stanley Hospital Sydney Australia St. Vincent’s Hospital Fortaleza Brazil Hospital de Messejana Athens Greece Evaggelismos Medical Center Dublin Ireland Mater Misericordiae University Hospital Tel HaShomer Israel Sheba Medical Center Udine Italy Azienda Ospedaliero Universitaria Santa Maria Della Misericordia Milan Niguarda Ca’Granda Hospital Auckland New Zealand Auckland Hospital Riyadh Saudi Arabia King Faisal Specialist Hospital & Research Centre Singapore National Heart Centre Singapore Bratislava Slovakia National Institute of Cardiovascular Diseases A Coruña Spain Complexo Hospitalario Universitario a Coruna Madrid Hospital Universitario Puerto de Hierro Stockholm Sweden Karolinska University Hospital Scania Skane University Hospital Linköping University Hospital Linkoping 10/20/2015 IMACS First Annual Report

Appendix 2. IMACS – Information Collected Data Collected Pre-Implant Implant 1 week/ 1 month Discharge 3 months/ every 6 months Demographics X   Medical Support Status Comorbidities Hemodynamics Medications Laboratory Medical Condition Exercise Function Patient Status Device information Device details Device parameters Adverse Event Reminders Chronology of Hospital Time 10/20/2015 IMACS First Annual Report

Appendix 3. Potential Covariates used in Multivariable Model Demographics Age, Male, White, College, Married, Body Mass Index , Body Surface Area, Ethnicity Patient Profile Levels NYHA 4 Comorbidities Previous Cancer, Ascites, Diabetes, Smoker, Alcohol Abuse, Cardiovascular accident (CVA), Peripheral vascular disease (PVD), Carotid artery disease, Diagnosis – coronary artery disease, History of CABG, History of Valve surgery, ICD Implant Information Concomitant surgery, Continuous flow device, Bi-ventricular placement, Failure to wean, Post cardiac operation Pre-Implant Laboratory Values Cholesterol, INR, Sodium, Albumin, Total Bilirubi,n SGOT/AST, White blood cell (WBC), Blood urea nitrogen (BUN), Creatinine, Pre-albumin Device Strategy @ Implant Destination Therapy Pre-Implant Interventions Ventilator, IABP, Inotropes, Dialysis Hemodynamics (Pre-Implant) Systolic blood pressure, Diastolic book pressure, Right atrial pressure, Cardiac Output, Cardiac Index, LVEDD%, Pulmonary Wedge pressure, Pulmonary diastolic pressure, Pulmonary systolic pressure, PVR-Cardiac Index, PVR-Cardiac Output, LVEF < 20, Severe RVEF 10/20/2015 IMACS First Annual Report